Silbert

Cassava | Tomorrow - scheduled end of phase IIb | Jackpot?

Long
Silbert Mis à jour   
NASDAQ:SAVA   Cassava Sciences, Inc.
Is SAVA about to blow up soon? The phase IIb will be most likely done by tomorrow whereby the analysis and evaluation of the results is scheduled for May. So there might be one last pullback before the stock will pulverize the last highs (in case the results are positive!). As a consequence of that I will look for good entries to ride the stock to at least 20$ per share :).
Commentaire:
Launch successful :). The NIH is funding another $2.5 million, which might be a good sign for positive phase 2b results.
Commentaire:
The results aren't published yet, but the expectations grow! The stock is rising sharply :)

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.